Vision and the Brain: Understanding Cerebral Visual Impairment in Children(Print)
by American Printing House for the Blind
Last verified June 15, 2026 · classified June 17, 2026
What it is
Summary
AI-generated from vendor-published content · June 17, 2026
This is a professional reference book on Cerebral Visual Impairment (CVI) — a brain-based visual condition that is now the leading cause of visual impairment in children in developed countries. It covers the neuroscience of how CVI differs from ocular vision loss, assessment approaches, and evidence-based intervention strategies for educators, therapists, and families. The print edition is made to order through APH, so expect a 10–14 business day lead time before it ships. This is a resource for the people supporting a child with CVI, not a tool the child uses directly — it's most useful for TVIs (Teachers of the Visually Impaired), OTs, SLPs, and informed parents who want to understand the condition deeply enough to advocate effectively or design appropriate interventions.
Quick Facts Catalog facts · auto-generated
- Out of pocket
- School district
- Vocational rehab
What Setup Looks Like
- Out of the box
Open and read — no setup required for the print edition.
Getting it
Many states lend devices like this for free trial periods — find your state's AT lending program.
Where to Get It
Some links may be affiliate links — WhatCanHelp may earn a small commission from purchases at no extra cost to you. More on affiliates →
How to Fund This
Equipment like this is often pursued through official state programs. These are common starting points — each program decides its own eligibility and what it covers, so the first step is always a phone call.
Compare & explore
Sources & fine print
Vendor facts (name, price, platforms, vendor link) sourced from American Printing House for the Blind — view on vendor site; last verified June 15, 2026.
Classification & description AI-generated from vendor-published content on June 17, 2026 · confidence: high. Vendor specs may lag; verify before relying on details in a clinical or funding artifact.